Hot Pursuit     11-Jun-24
Biocon Ltd soars 2.25%, up for fifth straight session
Biocon Ltd is quoting at Rs 347.55, up 2.25% on the day as on 12:44 IST on the NSE. The stock is up 45.36% in last one year as compared to a 25.46% spurt in NIFTY and a 54.03% spurt in the Nifty Pharma.

Biocon Ltd gained for a fifth straight session today. The stock is quoting at Rs 347.55, up 2.25% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is up around 0.34% on the day, quoting at 23337.55. The Sensex is at 76691.49, up 0.26%. Biocon Ltd has risen around 15.22% in last one month.

Meanwhile, Nifty Pharma index of which Biocon Ltd is a constituent, has risen around 4.56% in last one month and is currently quoting at 19774.7, up 0.14% on the day. The volume in the stock stood at 50.37 lakh shares today, compared to the daily average of 103.49 lakh shares in last one month.

The benchmark June futures contract for the stock is quoting at Rs 348.05, up 2.1% on the day. Biocon Ltd is up 45.36% in last one year as compared to a 25.46% spurt in NIFTY and a 54.03% spurt in the Nifty Pharma index.

The PE of the stock is 377.5 based on TTM earnings ending March 24.

Previous News
  Biocon Ltd spurts 1.83%, gains for third straight session
 ( Hot Pursuit - 22-Mar-24   13:05 )
  Biocon Biologics set to introduce YESAFILI®, a proposed biosimilar to EYLEA® in Canadian market
 ( Corporate News - 04-Mar-24   09:30 )
  Indices edge lower, Nifty near 18,300; breadth positive
 ( Market Commentary - Mid-Session 24-May-23   09:32 )
  Biocon Ltd down for fifth straight session
 ( Hot Pursuit - 10-May-22   13:35 )
  Biocon records turnaround PAT of Rs 660 cr in Q3
 ( Hot Pursuit - 09-Feb-24   14:12 )
  Biocon consolidated net profit rises 31.27% in the March 2023 quarter
 ( Results - Announcements 24-May-23   07:33 )
  Express Scripts lists Biocon subsidiary's Semglee as a preferred glargine brand on NPF
 ( Hot Pursuit - 21-Oct-21   10:46 )
  Biocon receives Complete Response Letter for Biologics License Application
 ( Corporate News - 09-Feb-24   09:11 )
  Biocon rallies after recording PAT of Rs 126 cr in Q2 FY24
 ( Hot Pursuit - 12-Nov-23   18:17 )
  Biocon update on subsidiary's biologics license application for Insulin-R product
 ( Corporate News - 07-Jan-23   12:33 )
  Biocon gains on USFDA nod for insulin glargine injection
 ( Hot Pursuit - 12-Jun-20   09:15 )
Other Stories
  Dhanlaxmi Bank gains as gross advances rises 6% YoY in Q1 FY25
  05-Jul-24   15:27
  HDFC Bank Ltd leads losers in 'A' group
  05-Jul-24   15:00
  Shilpa Medicare sizzles after Unicycive gets positive results in clinical trials of OLC
  05-Jul-24   14:52
  Manugraph India Ltd leads losers in 'B' group
  05-Jul-24   14:45
  NSE SME Nephro Care India rallies on listing day
  05-Jul-24   14:45
  ESAF SFB total deposits jumps 33% YoY in Q1
  05-Jul-24   14:43
  Utkarsh SFB deposits climb 30% YoY in Q1 FY25
  05-Jul-24   14:35
  Volumes soar at Medplus Health Services Ltd counter
  05-Jul-24   14:30
  Financials stocks slide
  05-Jul-24   14:00
  Banking stocks edge lower
  05-Jul-24   14:00
Back Top